Mario Eid1
Venise Abi Kheir
Maya Bizri
Amine Larnaout
Samer El Hayek- 1Department of Psychiatry, Lebanese American University, Beirut, Lebanon
- 2University of Balamand Medical School, University of Balamand, El Koura, Lebanon
- 3Department of Psychiatry, American University of Beirut Medical Center, Beirut, Lebanon
- 4Razi Hospital, Faculty of Medicine, University of Tunis El Manar, Tunis, Tunisia
- 5American Center for Psychiatry and Neurology, Dubai, United Arab Emirates
Background: Somatic symptom and related disorders (SSRDs) are prevalent worldwide, but their expression, help-seeking patterns, and management are strongly shaped by cultural context. In the Arab world, where mental health stigma and distinct explanatory models are common, SSRDs remain under-studied despite their clinical and public health significance.
Methods: We conducted a narrative review of 35 studies published through June 2025 on SSRDs in Arab populations. Searches of PubMed, Scopus, and Google Scholar identified observational studies, case reports, and cross-sectional surveys addressing Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) SSRD categories.
Results: Somatic symptoms disorder (SSD) was the most frequently investigated disorder, with prevalence ranging from 12% to 46%. Across studies, female gender, low educational attainment, chronic medical comorbidity, and trauma history were consistent risk factors. Common symptoms included muscle, back, and abdominal pain, often accompanied by depression and anxiety. Illness anxiety disorder, functional neurological symptom disorder, and factitious disorders were less studied but carried important diagnostic, cultural, and service delivery challenges.
Conclusion: SSRDs are common but under-recognized in Arab contexts. Effective management requires early detection in primary care, culturally sensitive communication, and disorder-specific interventions. Future research should broaden the scope beyond SSD, examine longitudinal and trauma-related pathways, and evaluate culturally adapted models of care.
1 Introduction
Medically unexplained symptoms (MUS) are persistent bodily complaints for which adequate examination does not reveal sufficiently explanatory structural or other specified pathology (1). MUS are common worldwide and occur at particularly high rates in non-Western cultures and among ethnic minorities in high-income countries (2, 3). Their presentation is influenced by sociocultural factors, including linguistic tendencies to convey distress through bodily idioms and culturally shaped health beliefs (4). Distinct regional patterns have been described: for example, African populations may report heat sensations, numbness, and diffuse pain (5); Spanish primary care patients frequently present with backache (6); and patients in Saudi Arabia often report pain and neurological symptoms (7).
The term somatization denotes the expression of psychological distress through physical symptoms that lack an adequate medical explanation. In earlier classifications, persistent physical symptoms were grouped under “somatoform disorders”, which were defined as physical symptoms suggesting a physical disorder without demonstrable organic findings and with strong evidence of psychological causation (8). With the publication of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), this category was replaced by “Somatic Symptom and Related Disorders” (SSRDs) (9). The text revision DSM-5-TR includes somatic symptom disorder (SSD), illness anxiety disorder, functional neurological symptom disorder (FNSD), factitious disorder, and factitious disorder imposed on another. Disorders previously grouped under somatization, e.g., body dysmorphic disorder and pain disorder, are now classified separately (10). This updated categorization emphasizes the presence of distressing physical symptoms along with disproportionate thoughts, feelings or behaviors, rather than the absence of medical explanation, and underscores the interplay between physical symptoms and mental health (1).
Globally, population surveys indicate that approximately 26–35% of adults attending primary care meet criteria for a somatoform or SSD, and cross-cultural reviews emphasize that somatization is a universal phenomenon, with differences occurring primarily in symptom expression rather than overall prevalence (11, 12). Given their high prevalence, functional impairment, and complex presentation, SSRDs represent a major yet under-recognized public health concern, particularly in regions where cultural factors strongly influence the expression and interpretation of psychological distress.
The Arab region comprises 22 countries with a combined population of approximately 425 million, nearly 60% of whom are under the age of 25 (13). Psychiatric disorders account for an estimated 5.6% of the total disease burden in the region, with depressive disorders contributing the largest share of disability-adjusted life years (14). Suicide is also a growing concern, with 26,000 deaths reported in the Eastern Mediterranean Region in 2016 (15). Despite this burden, mental health service provision remains limited, averaging 7.3 mental health workers and 4.2 psychiatric beds per 100,000 population, compared with 43.5 and 35, respectively, in Europe (16).
In the Arab world, distinct explanatory models of organic and psychiatric illnesses are common (17, 18). Explanatory models encompass the patient and family’s beliefs about illness causes, personal and social meanings, and expected management. These beliefs often incorporate biomedical, psychological, and supernatural elements and shape treatment outcomes (19). In this regard, cultural, religious, and traditional values play a central role in shaping how mental illness is perceived and expressed in Arab societies (20, 21). Socioeconomic challenges, including poverty, gender inequality, stigma, and limited access to specialized care, further influence health-seeking behaviors and the likelihood of receiving appropriate mental health services (22, 23). These sociocultural and structural factors are particularly relevant to SSRDs, as they can affect both the types of symptoms reported and the diagnostic process. For clinicians working in multicultural settings, understanding such cultural dynamics is crucial, because differences in explanatory models, cultural values, and doctor-patient relationship preferences are known to cause communication problems and misinterpretation of symptoms (24).
Although global evidence indicates broadly comparable prevalence rates for SSRDs, reported figures across studies often diverge because of differences in diagnostic criteria, sampling methods, and cultural interpretations of MUS, rather than genuine epidemiological variation (25–29). However, little is known about how these patterns manifest specifically within Arab populations, and no comprehensive review has yet synthesized the available evidence.
The present narrative review addresses this gap by summarizing published research on the prevalence, epidemiological characteristics, and associated factors of SSRDs in Arab countries. It also identifies knowledge gaps and outlines recommendations to guide culturally appropriate clinical practice and policy in the region.
2 Material and methods
Given the heterogeneity of diagnostic labels (e.g., somatoform disorder, somatization, bodily distress, etc.), study designs (e.g., case reports, cross-sectional surveys), populations (primary care, hospital outpatients, community samples, refugees, and students) and outcome measures (prevalence, symptom patterns, risk factors, and comorbidities), a formal systematic review or meta-analysis was not feasible. Instead, a narrative review was conducted, providing a comprehensive descriptive synthesis of the diverse data and integrating the relevant cultural context.
A literature search was conducted in PubMed, MEDLINE, Scopus, and Google Scholar from database inception to June 15, 2025. Search terms included "somatic symptom disorder", “somatoform disorder”, “somatization”, "illness anxiety", "hypochondriasis", "conversion disorder", "functional neurological symptom disorder", and "factitious disorder", in combination with "Arab countries" and the names of individual Arab nations. Reference lists of relevant publications were also screened to identify additional studies. No formal language restrictions were imposed.
Eligible studies met the following criteria: (1) conducted in Arab populations, and (2) addressed SSRDs or related diagnoses consistent with DSM-5-TR categories. Observational studies, cross-sectional studies, and case reports were included to capture both clinical trends and culturally specific presentations. For each eligible study, the following information was extracted: study design, country, setting and participant characteristics; diagnostic criteria and screening instruments; sample size and prevalence estimates; symptom patterns; risk factors and comorbidities; management approaches; and authors’ key conclusions. Findings from the included studies were narratively synthesized.
3 Results
A total of 35 studies conducted across various Arab countries were identified, each addressing a specific subtype or presentation of SSRDs. Of these, 18 studies examined SSD, seven addressed illness anxiety disorder, four investigated FNSD, five focused on factitious disorder, and one described a culture-bound syndrome (Dhat syndrome).
A conceptual framework illustrating the manifestation of SSRDs in Arab populations is presented in Figure 1. This framework integrates DSM-5-TR diagnostic categories with common clinical features and sociocultural determinants specific to the region, offering a contextual lens for interpreting the findings described below.
Figure 1. Somatic symptom and related disorders in the Arab World: conceptual framework. Legend: This conceptual framework illustrates how somatic symptom and related disorders (SSRDs), as classified by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), are expressed and influenced within Arab populations. The left layer outlines the primary diagnostic categories under the SSRDs umbrella: somatic symptom disorder, illness anxiety disorder, functional neurological symptom disorder, and factitious disorder. The middle layer presents the core clinical features frequently observed in Arab populations. These include a predominance among females, common symptom patterns (e.g., musculoskeletal symptoms, headaches), high rates of psychiatric comorbidities such as depression, anxiety, and trauma-related symptoms, and frequent general healthcare visits. The right layer identifies key cultural and systemic modifiers that shape how these disorders are experienced, interpreted, and treated. These include stigma surrounding mental illness, religious or supernatural attributions, and limited access to psychiatric services, among others. This model underscores the necessity of using a culturally informed, biopsychosocial approach to diagnosing and managing SSRDs in Arab contexts.
3.1 Somatic symptom disorder
3.1.1 Study origins and sample sizes
Studies on SSD originated from eight Arab countries: Bahrain (n=1) (30), Kuwait (n=1) (25), Oman (n=2) (31, 32), Palestine (n=2) (33, 34), Qatar (n=4) (35–38), Saudi Arabia (n=3) (7, 39, 40), Tunisia (n=1) (41), and the United Arab Emirates (UAE) (n=2) (42, 43). Two studies addressed Syrian refugees (n=2) (44, 45).
Sample sizes varied from 38 (31) to 2,000 participants (32). Details of these studies and their main findings are summarized in Table 1.
Table 1. Summary of studies discussing somatic symptom disorder in the Arab world.
3.1.2 Study settings and populations
Most studies were conducted in primary care settings and involved adults attending primary health care clinics (25, 32, 34–38, 40, 42). Other populations included hospital-based patients seeking treatment or follow-up services (7, 33, 43), community-dwelling adults (39, 41), Syrian refugees residing in host countries (44, 45), and medical students (30).
3.1.3 Prevalence
The prevalence of somatic symptoms/somatization ranged from 12% (35, 37, 42) to 46% (30). Conversely, the prevalence of “somatoform disease” ranged from 4% (43) to 32.5% (34).
One study reported high somatic symptom scores in 52.6% of participants (39). Among Syrian refugees, bodily distress was common, ranging from 41.7% (45) to 49.1% (44).
3.1.4 Risk factors
Across studies, female gender was the most frequently reported risk factor (30, 32, 39, 40, 44, 45).
Several studies reported gender-specific patterns: differences in somatic symptoms by age group (35, 37), level of education (38), nationality, and profession (36). Men were more likely to report physical illnesses during both childhood and adulthood, whereas women showed higher rates of psychiatric family history, prolonged depressive reactions, and dissatisfaction with social life (37).
Other significant risk factors included younger age (39), lower education level (32, 42, 45), lower socioeconomic status (39, 45), chronic medical comorbidities (32, 34, 45), positive psychiatric family history (45), and high depression and anxiety scores (34, 44, 45).
Past trauma (44, 45) and trauma-related factors were also prominent. These included childhood abuse, exposure to traumatic events, and emotional neglect (33, 38), with the greatest impact observed in males, individuals aged 31–40 years, those with divorced parents, and those with less than secondary school education (33). In Tunisia, peri-traumatic dissociation was independently associated with somatic complaints one year after the Arab Spring events. Somatic symptoms also mediated the relationship between peri-traumatic dissociation and reduced physical and mental quality of life (41).
3.1.5 Symptomatology
Commonly reported symptoms included pain (7), particularly:
● Muscle and back pain (34, 37, 42, 44, 45),
● Stomach pain (35),
● Aches in arms, legs, and joints (36, 44, 45),
● Headaches (38, 40) (42, 45).
Two studies found that nearly half of affected individuals reported three or more symptoms (35, 42).
3.1.6 Comorbidity
Somatization was the most prevalent psychiatric condition comorbid with organic illnesses (25). Compared with healthy individuals, those with SSD visited physicians more frequently (34). One study noted that over one-third (41.6%) did not receive pharmacological treatment (7).
Somatization frequently co-occurred with depression and anxiety (36). In addition, patients with undifferentiated somatoform disorder showed lower scores in working memory, executive functioning, and sleep quality, and higher anxiety scores compared to healthy controls (31).
3.2 Illness anxiety disorder
Studies on illness anxiety originated from Egypt (n=2) (46, 47), Jordan (n=1) (48), Lebanon (n=1) (49), Saudia Arabia (n=2) (50, 51), and the UAE (n=2) (46, 52). Details of these studies and their main findings are presented in Table 2.
Table 2. Summary of studies discussing illness anxiety disorder in the Arab world.
Sample sizes ranged from 105 (49) to 1,173 participants (47). Populations included parents of children with cancer (49), physicians reporting on illness anxiety by proxy in parents (46), and medical students (47, 48, 50–52).
Reported prevalence ranged from 9.3% (52) to 38.8% (51) among medical students, and reached 21% among parents of children with cancer (49).
In medical students, health anxiety was significantly associated with lower quality of life (47), younger age (50), and a planned/recent visit to a doctor/psychiatrist (48, 50), while female gender and lack of academic satisfaction emerged as significant predictors in one study (47). Among parents of children with cancer, health anxiety was significantly associated with feelings of helplessness, lower acceptance, perceived insufficient income, and personal illness or sickness of a family member/friend (49). The most cited explanation for parental fears was an exaggeration of actual existing symptoms (46).
3.3 Functional neurological symptom disorder
Studies on FNSD originated from Oman (n=1) (53), Qatar (n=1) (54), and Saudi Arabia (n=2) (55, 56). Details of these studies and their main findings are presented in Table 3.
Table 3. Summary of studies discussing functional neurological symptom disorder in the Arab world.
Sample sizes ranged from 25 children with dissociative conversion disorder (53) to 473 adult referrals to a neurology-psychiatry clinic (56). In the latter, the prevalence of FNSD was 11%, with psychogenic non-epileptic seizures (PNES) being the predominant type (56).
In studies focusing on individuals with seizures, the prevalence of PNES ranged from 1.8% (55), to 25 of 71 confirmed seizure diagnoses in an epilepsy monitoring unit in Qatar; this included 20 patients with PNES alone and 5 with both PNES and epilepsy (54).
Risk of FNSD was highest among women and patients reporting family conflict or sexual abuse (56). Compared to those with epilepsy, individuals with PNES were more likely to be native Arabs, to have more frequent seizures, and to report higher depression scores and greater fatigue (54).
3.4 Factitious disorder and other conditions
A total of five case reports addressed factitious disorders in the Arab world. These included one prospective case series from Oman (57) and case reports from Jordan (58), Oman (59), and Saudi Arabia (60, 61). One additional case report discussed Dhat syndrome in Oman (62). Details of these studies, including demographics, clinical presentations, and outcomes, are summarized in Table 4.
Table 4. Summary of studies discussing factitious disorder and Dhat syndrome in the Arab world.
The case series (n=19) reported a prevalence of factitious disorder of 0.2%, with hemorrhagic presentations being the most common (57). The case reports described Münchausen syndrome in adults (60) and adolescents (58), and Münchausen by proxy in two infants (59, 61). The culture-bound Dhat syndrome case involved a young Omani male and suggested that the condition may be under-recognized in the region (62).
4 Discussion
In the 35 studies included in this review, SSRDs were documented across diverse Arab populations and clinical settings. Prevalence estimates for SSD ranged from 12% to 46%, while illness anxiety disorder and FNSD reached up to 38.8% and 11%, respectively, in specific subgroups. Factitious disorder and rare culture-bound presentations, such as Dhat syndrome, were reported only as isolated cases. These findings broadly align with international data; a systematic review of 32 studies from 24 countries identified a prevalence of at least one type of somatoform disorder between 26.2% and 34.8% in primary care, and up to 49% of individuals reported at least one MUS (12). European population studies likewise suggest that 8% to 20% of adults experience persistent functional symptoms, though prevalence varies by instrument and health-system context (63). Patterns of comorbidity and impairment are also consistent with global evidence: international cohorts demonstrate high rates of co-occurring anxiety and depressive disorders (64), frequent primary-care attendance, and significant work-related disability (65, 66).
Although prevalence patterns were broadly comparable to international data, the research focus within Arab studies remained narrow, emphasizing SSD over other SSRDs. Methodological heterogeneity, small sample sizes, and underrepresentation of certain countries further limited cross-study comparability. Despite these limitations, several cross-cutting themes emerged: (1) a high burden of psychiatric comorbidity, especially depression, anxiety, and trauma-related symptoms; (2) frequent co-occurrence with chronic medical illness; and (3) strong influence of sociocultural factors on symptom expression and help-seeking behavior. These patterns suggest that SSRDs in Arab contexts share core features with global presentations but are shaped by region-specific cultural norms, healthcare structures, and stigma toward mental illness.
4.1 Somatic symptom disorder
SSD was by far the most studied SSRD in Arab populations, with consistent associations with female gender, lower educational attainment, chronic medical conditions, and psychological distress, including depression, anxiety, and trauma-related symptoms. Research has identified a range of potential risk factors for SSD, including female gender (67), sociocultural factors (68), childhood trauma (69), genetic predisposition (70), and specific personality traits (71).
Arab refugees in host countries exhibited high rates of bodily distress, mirroring findings from refugee populations elsewhere (72, 73). This is often linked to cumulative trauma exposure, displacement stressors, socioeconomic hardship, and poor access to continuity of care (74).
Muscle and back pain were the most reported somatic symptoms, and affected individuals had comorbid mental health problems, including depression, anxiety, and trauma-related symptoms. These associations are consistent with global findings (28, 64, 69, 75) and reflect a bidirectional relationship, where psychological distress can intensify somatic symptoms, and persistent somatic symptoms can worsen psychiatric morbidity.
A particularly important finding in the Arab literature is the frequent co-occurrence of SSD with chronic organic illnesses. This complicates diagnosis and management, as clinicians must avoid both missing an underlying physical disorder and over-investigating symptoms that may have a psychogenic component (76). Furthermore, the associated history of trauma and high depression and anxiety scores reinforces the need for integrated medical–psychiatric care. Without such integration, repeated investigations and delayed recognition of underlying distress are likely to persist, increasing both patient burden and healthcare costs.
The optimal management of SSD follows a stepped-care approach grounded in the biopsychosocial model, involving close collaboration among primary-care physicians, relevant medical specialists, and mental health professionals (77). One potential framework for treatment is the CARE MD model. CARE MD is a systematic primary care management framework. It stands for Consultation, Assessment, Regular visits, Empathy, Medical/psychiatric interface, and Do no harm (78, 79). Although the evidence for this model is limited, it builds on established principles of structured care for patients with SSD/SSRD (80–82). The model emphasizes scheduled follow-up, legitimization of physical symptom distress, minimization of unnecessary investigations, empathic communication, and coordinated liaison with mental-health services as cornerstones of treatment (78, 79). In Arab contexts, these principles may be particularly relevant given the influence of stigma, supernatural explanatory models (e.g., jinn, evil eye), and the common practice of consulting religious or traditional healers before psychiatric services (83, 84). For example, a primary-care clinician managing a patient who attributes chronic chest pain to the evil eye might apply the CARE MD framework by scheduling regular visits to build trust and continuity, validating the patient’s suffering without endorsing supernatural causation, and engaging family members or religious and community figures, when applicable, to align biomedical and spiritual perspectives. Such culturally attuned use of CARE MD principles can reduce unnecessary investigations and enhance treatment adherence.
4.2 Other somatic symptoms and related disorders
Illness anxiety disorder in Arab populations was most often studied among medical students and caregivers of children with serious illnesses. Among medical students, the elevated rates of illness anxiety are consistent with the “medical student’s disease” phenomenon reported internationally (85), where increased health knowledge and academic pressure heighten health-related concerns and mental health burden (86). This suggests a need for university-based mental health programs that address both general stress management and health anxiety specifically. For parents of children with severe medical conditions, anxiety by proxy has been observed in other cultural settings (87, 88) and may contribute to increased healthcare utilization and child overmedicalization. In the Arab context, where family-centered care is highly valued, pediatric teams may need additional training to detect and address parental anxiety without undermining the therapeutic alliance.
Beyond illness anxiety, other SSRDs present distinct diagnostic and management challenges in the Arab context. FNSD, especially PNES, predominantly presented in young women and was frequently associated with trauma or family conflict. Misdiagnosis as epilepsy was common, which is consistent with global findings and has significant consequences, including unnecessary antiepileptic therapy and delayed psychiatric intervention (89–91). Limited access to diagnostic tools such as video-EEG monitoring in many Arab countries may contribute to this problem. Culturally embedded explanatory models, such as attributing seizures to supernatural causes, combined with limited expertise among healthcare providers, can further delay accurate diagnosis and hinder patient engagement in treatment (90, 92). These patterns suggest that in Arab contexts, improving access to neurodiagnostic testing and integrating culturally sensitive psychoeducation into early care pathways could reduce both diagnostic delay and inappropriate treatments.
Factitious disorders, though rare in the literature, present diagnostic and ethical challenges. Their underreporting in Arab research is likely multifactorial, reflecting stigma, medico-legal risks, and limited psychiatric service capacity for prolonged observation. Diagnostic complexity also contributes to under recognition, as differentiating factitious presentations from malingering or conversion disorders often requires multidisciplinary assessment and extended follow-up. Moreover, limited training in consultation-liaison psychiatry within the region may hinder systematic identification and reporting of such cases.
The single report of Dhat syndrome suggests that culture-bound syndromes may exist in Arab contexts but are seldom studied, possibly due to clinicians limited familiarity with such constructs. Beyond Dhat, other culture-bound syndromes have been reported in the region. For instance, Zār spirit possession, observed in North and East Africa and some Middle Eastern societies, manifests as dissociative episodes with behaviors such as shouting, head banging, laughing, or singing, attributed to spirit intrusion (93). Similarly, beliefs in jinn possession are common across Arab societies and may influence how patients interpret somatic and psychiatric symptoms (18). Such explanatory models often lead individuals to seek religious or traditional healing before psychiatric evaluation, potentially delaying diagnosis and treatment. Addressing these conditions requires culturally competent care and collaboration between mental health services and faith-based community resources.
4.3 Risk factors and cultural influences
Female gender emerged as a consistent risk factor for SSRDs, in line with worldwide trends (94–96). Several factors may explain this gender variation. To start with, Arab men tend to be less expressive about their illness and distress (94). This could be attributed to specific cultural norms related to the Arab world, wherein men must preserve their sense of masculinity as society defines it. Denying physical symptoms and distress can, therefore, result in men being less likely to present to the clinic with somatization. Moreover, men and women may perceive past medical experiences differently, with the former forgetting about their symptoms more readily than women (94, 97). Other potential explanations include variations in rates of anxiety and mood disorders, as well as abuse and violence between genders (98).
Cultural and religious factors influence not only who presents with SSRDs but also how symptoms are expressed. The Arab culture places a strong emphasis on the body and its sensations, while mental illness is often perceived as a sign of weakness or moral failing. Physical symptoms are, therefore, widely accepted as a legitimate expression of emotional distress. Moreover, religious beliefs and practices may influence the manifestation and interpretation of physical symptoms (99, 100). Consistent with Kleinman’s framework (101), explanatory models observed in Arab contexts often reflect culturally embedded meanings of illness, in which experiences such as jinn influence, the evil eye, or divine testing shape patients’ interpretation of symptoms and expectations of care (102). This cultural framing can also shape help-seeking behavior, as seen in several included studies where patients repeatedly sought biomedical consultations for physical complaints but were reluctant to accept psychiatric referral, and in the literature discussing how individuals may first consult religious or traditional healers rather than mental health professionals (103–105).
Clinicians must account for the cultural context when assessing and treating SSRDs in Arab populations. Culturally sensitive interventions, e.g., incorporating religious and spiritual components into treatment, may be effective. These interventions can include integrating religious practices, e.g., prayer, into treatment plans or utilizing culturally specific therapies, such as Hijama (cupping therapy), which is commonly used in Arab countries.
4.4 Implications for practice and policy
The limited availability of mental health services across the Arab region, combined with the central role of primary care in initial presentations, highlights the urgent need for clinician training in early detection and culturally sensitive communication regarding SSRDs. Primary healthcare providers should maintain a high index of suspicion for patients presenting with recurrent unexplained symptoms, to ensure early identification while minimizing unnecessary healthcare utilization. Culturally sensitive communication should be a core competency, helping clinicians explore psychological factors without alienating patients.
For SSD, patient-centered stepped care approaches that integrate the biopsychosocial approach into actual management (80–82) can reduce unnecessary investigations, while fostering trust, and improve treatment outcomes. For FNSD, particularly PNES, early diagnosis is critical to improving prognosis (106). During initial consultations, clinicians should conduct thorough mental health assessments that include screening for trauma history, psychosocial stressors, and comorbid psychiatric conditions. Physicians must also be trained in how to deliver the diagnosis clearly and empathetically. Recommended strategies include validating the patient's symptoms, naming the condition, explaining the neurobiological underpinnings (e.g., "the brain temporarily shuts down from overload"), clarifying which treatments are effective, and managing expectations (107, 108). After communicating the diagnosis, the subsequent treatment stage encompasses providing care through a multidisciplinary team that includes a neurologist, psychiatrist, psychologist, rehabilitation medicine physician, and physiotherapist (108). For illness anxiety disorder, particularly among medical students and caregivers, targeted educational interventions can help recalibrate health perceptions and reduce excessive healthcare utilization.
To support clinical implementation, Figure 2 presents a culturally responsive care model tailored to Arab primary care. It integrates diagnostic pathways and screening tools that reflect culturally relevant explanatory models, aiming to enhance patient engagement, therapeutic rapport, and treatment outcomes.
Figure 2. A culturally responsive clinical pathway for managing somatic symptom and related disorders in Arab primary care settings. Legend: This flowchart outlines a culturally sensitive, stepwise approach to identifying and managing somatic symptom and related disorders (SSRDs), including somatic symptom disorder, illness anxiety disorder, and functional neurological symptom disorder, in Arab populations. Initial screening is conducted using validated Arabic tools, including the Patient Health Questionnaire-15 (PHQ-15), Somatic Symptom Scale-8 (SSS-8), Generalized Anxiety Disorder-7 (GAD-7), and Short Health Anxiety Inventory (SHAI). A targeted neurological exam can be considered to further assess functional symptoms. Once SSRDs indicators are identified, the clinician explores the patient's explanatory model. For individuals who hold supernatural or culturally bound beliefs (e.g., attribution to jinn, the evil eye, fate, or curses), the care process begins with spiritual and cultural validation, through education, reassurance, and family involvement. This is followed by a gradual introduction of psychosocial explanations, aiming to build trust and prepare for transition to integrated and structured care. For patients more open to psychological models of distress, clinicians can use culturally sensitive language to explain the mind–body connection and initiate treatment such as cognitive behavioral therapy (CBT) or selective serotonin reuptake inhibitors (SSRIs). Incorporating structured reassurance that limits unnecessary investigations while validating suffering is necessary. Both pathways converge on multidisciplinary team care, including collaboration among primary care, psychiatry, neurology, psychology, occupational therapy, social services, and community-based support.
At the policy level, integrating mental health services into primary care, expanding the regional mental health workforce, and developing locally relevant clinical guidelines are urgent priorities. These measures would address the current fragmentation of services, where patients often cycle through repeated biomedical consultations without psychiatric referral. Training primary care providers in culturally informed assessment and communication, drawing on evidence-based approaches such as the WHO mhGAP Intervention Guide (109, 110), can improve early recognition and reduce unnecessary investigations. Public awareness campaigns, ideally co-designed with community and religious leaders, can reduce stigma, encourage help-seeking, and normalize discussion of the mind–body connection, reframing mental health care as compatible with cultural and religious values. Policy should also incentivize research on underrepresented SSRDs and vulnerable groups, such as refugees, medical students, and rural populations, to ensure equitable service development. Investment in longitudinal and intervention studies is essential to inform sustainable, scalable models of care that reflect both the cultural context and the resource realities of the Arab region.
4.5 Limitations
This review has several limitations. The included studies were heterogeneous in design, diagnostic terminology, screening tools, and populations, limiting direct comparison. Most employed cross-sectional designs and self-report measures, reducing diagnostic precision. Small sample sizes and reliance on convenience sampling limited generalizability. Few or no studies examined longitudinal outcomes, cultural explanatory models, or the healthcare system impact of SSRDs. Given these limitations, the review should be interpreted as a broad synthesis rather than a definitive measure of prevalence or causality. Future work should employ validated DSM-5-TR–aligned tools, investigate gender-specific and culturally informed pathways, and assess the effectiveness of culturally adapted interventions in routine care.
5 Conclusion
SSRDs are prevalent in Arab populations, with SSD most frequently studied and marked by high psychiatric comorbidity, overlap with chronic medical illness, and culturally shaped help-seeking patterns. Gender differences and stigma influence symptom expression and delay psychiatric referral. Improving outcomes will require early recognition in primary care, culturally sensitive communication, and patient-centered stepped care approaches. Future research should explore longitudinal outcomes, trauma pathways, and the effectiveness of culturally adapted interventions to guide locally relevant policy and clinical guidelines.
Author contributions
ME: Conceptualization, Investigation, Writing – original draft, Data curation. VA: Writing – review & editing. MB: Writing – review & editing. AL: Writing – review & editing. SE: Supervision, Writing – review & editing, Conceptualization, Writing – original draft.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Marks EM and Hunter MS. Medically Unexplained Symptoms: an acceptable term? Br J Pain. (2015) 9:109–14. doi: 10.1177/2049463714535372
2. Creed F, Henningsen P, and Fink P. Medically unexplained symptoms, somatisation and bodily distress: developing better clinical services. Cambrigde: Cambridge University Press (2011).
3. Wainberg ML, Scorza P, Shultz JM, Helpman L, Mootz JJ, Johnson KA, et al. Challenges and opportunities in global mental health: a research-to-practice perspective. Curr Psychiatry Rep. (2017) 19:28. doi: 10.1007/s11920-017-0780-z
4. Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry. (1988) 145:1358–68. doi: 10.1176/ajp.145.11.1358
5. Ohaeri JU and Odejide OA. Somatization symptoms among patients using primary health care facilities in a rural community in Nigeria. Am J Psychiatry. (1994) 151:728–31. doi: 10.1176/ajp.151.5.728
6. Lobo A, Garcia-Campayo J, Campos R, Marcos G, and Perez-Echeverria MJ. Somatisation in primary care in Spain: I. Estimates of prevalence and clinical characteristics. Working Group for the Study of the Psychiatric and Psychosomatic Morbidity in Zaragoza. Br J Psychiatry. (1996) 168:344–8. doi: 10.1192/bjp.168.3.344
7. Alanazi AO, Aljohani RA, Aljohani MF, Alhussaini AA, Alnemer FK, Qasim SS, et al. Epidemiological features and clinical manifestations of patients with somatoform disorder at a tertiary medical city in riyadh, Saudi Arabia. Cureus. (2021) 13:e19799. doi: 10.7759/cureus.19799
8. Kallivayalil RA and Punnoose VP. Understanding and managing somatoform disorders: Making sense of non-sense. Indian J Psychiatry. (2010) 52:S240–245. doi: 10.4103/0019-5545.69239
9. APA. Desk reference to the diagnostic criteria from DSM-5. Arlington, VA: American Psychiatric Publishing (2013).
10. APA. Diagnostic and statistical manual of mental disorders: DSM-5-TR (Fifth edition, text revision) (2022). American Psychiatric Association Publishing. Available online at: https://www.psychiatry.org:443/psychiatrists/practice/dsmfiles/559/dsm.html (Accessed July 7, 2025).
11. Al Busaidi ZQ. The concept of somatisation: A cross-cultural perspective. Sultan Qaboos Univ Med J. (2010) 10:180–6. doi: 10.18295/2075-0528.1184
12. Haller H, Cramer H, Lauche R, and Dobos G. Somatoform disorders and medically unexplained symptoms in primary care. Deutsches Ärzteblatt Int. (2015) 112:279–87. doi: 10.3238/arztebl.2015.0279
13. RBAS. Arab human development report 2016: youth and the prospects for human development in a changing reality. In: Regional bureau for arab states (RBAS), human development reports. Washington, DC, USA: United Nations Development Programme (UNDP) (2017). Available online at: https://hdr.undp.org/content/arab-human-development-report-2016-youth-and-prospects-human-development-changing-realityfiles/553/arab-human-development-report-2016-youth-and-prospects-human-development-changing-reality.html (Accessed June 9, 2025).
14. GBD 2015 Eastern Mediterranean Region Mental Health Collaborators.The burden of mental disorders in the Eastern Mediterranean region 1990-2015: findings from the global burden of disease 2015 study. Int J Public Health. (2018) 63:25–37. doi: 10.1007/s00038-017-1006-1
15. Naghavi M. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. BMJ. (2019) 364:l94. doi: 10.1136/bmj.l94
16. WHO. Mental health atlas 2014. In: World health organization, mental health, brain health and substance use (MSD), vol. 69. Geneva, Switzerland: World Health Organization (2014). Available online at: https://www.who.int/publications/i/item/mental-health-atlas-2014files/547/mental-health-atlas-2014.html (Accessed June 9, 2025).
17. Arabiat D, Whitehead L, Al Jabery M, Hamdan-Mansour A, Shaheen A, and Abu Sabbah E. Beliefs about illness and treatment decision modelling during ill-health in arabic families. J Multidiscip Healthc. (2021) 14:1755–68. doi: 10.2147/jmdh.S311900
18. Lim A, Hoek HW, and Blom JD. The attribution of psychotic symptoms to jinn in Islamic patients. Transcultural Psychiatry. (2015) 52:18–32. doi: 10.1177/1363461514543146
19. Dinos S, Ascoli M, Owiti JA, and Bhui K. Assessing explanatory models and health beliefs: An essential but overlooked competency for clinicians. BJPsych Adv. (2017) 23:106–14. doi: 10.1192/apt.bp.114.013680
20. Fakhr El-Islam M. Arab culture and mental health care. Transcultural Psychiatry. (2008) 45:671–82. doi: 10.1177/1363461508100788
21. Zolezzi M, Alamri M, Shaar S, and Rainkie D. Stigma associated with mental illness and its treatment in the Arab culture: A systematic review. Int J Soc Psychiatry. (2018) 64:597–609. doi: 10.1177/0020764018789200
22. Ibrahim NK. Epidemiology of mental health problems in the middle east. In: Laher I, editor. Handbook of healthcare in the arab world. Switzerland: Springer International Publishing (2021). p. 133–49. doi: 10.1007/978-3-030-36811-1_12
23. Zeinoun P, Akl EA, Maalouf FT, and Meho LI. The arab region's contribution to global mental health research, (2009–2018): A bibliometric analysis. Front Psychiatry. (2020) 11. Available online at: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00182 (Accessed July 7, 2025).
24. Stubbe DE. Practicing cultural competence and cultural humility in the care of diverse patients. Focus (Am Psychiatr Publ). (2020) 18:49–51. doi: 10.1176/appi.focus.20190041
25. Alkhadhari S, Alsabrrie AO, Ohaeri JU, Varghese R, Zahid MA, and Mulsant BH. Mental and physical comorbidity in an Arab primary health care setting. BMC Psychiatry. (2018) 18:313. doi: 10.1186/s12888-018-1903-8
26. Garrusi B, Danaei M, and Aboosaeidi R. The prevalence and predictive factors of somatization and its relationship with anxiety and depression in Iranian population. J Prev Med Hygiene. (2019) 60:E400–6. doi: 10.15167/2421-4248/jpmh2019.60.4.1006
27. Glise K, Ahlborg G, and Jonsdottir IH. Prevalence and course of somatic symptoms in patients with stress-related exhaustion: does sex or age matter. BMC Psychiatry. (2014) 14:118. doi: 10.1186/1471-244X-14-118
28. Löwe B, Levenson J, Depping M, Hüsing P, Kohlmann S, Lehmann M, et al. Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis. psychol Med. (2022) 52:632–48. doi: 10.1017/S0033291721004177
29. Wu Y, Tao Z, Qiao Y, Chai Y, Liu Q, Lu Q, et al. Prevalence and characteristics of somatic symptom disorder in the elderly in a community-based population: a large-scale cross-sectional study in China. BMC Psychiatry. (2022) 22:257. doi: 10.1186/s12888-022-03907-1
30. Abdelaziz A, Al-Utaybi K, Al-Haris J, Al-Qahtani T, Al-Ghamlas A, Jahrami H, et al. Prevalence and severity of somatic symptoms, depression and anxiety among medical students at the Arabian Gulf University: comparison between second and sixth year. Arab J Psychiatry. (2017) 28:69–75. doi: 10.12816/0036883
31. Al-Adawi S, Al-Zakwani I, Obeid YA, and Zaidan Z. Neurocognitive functioning in women presenting with undifferentiated somatoform disorders in Oman. Psychiatry Clin Neurosci. (2010) 64:555–64. doi: 10.1111/j.1440-1819.2010.02117.x
32. Alalawi NM, Al Salmani AA, Aljabri MK, Azmi IS, Aljardani MM, Al Mandhari SS, et al. Epidemiology and prevalence of somatic symptom disorder at the primary care level in muscat, Oman: A cross-sectional study. Int J Psychiatry Med. (2022) 58:284–94. doi: 10.1177/00912174221088263
33. Halak E and Idris O. Family Risk Factors among people affected with Psychosomatic Disorders. Arab J Educ Psychol Sci. (2025) 446(6):966–39. doi: 10.21608/jasep.2025.402644
34. Nazzal Z, Maraqa B, Abu Zant M, Qaddoumi L, and Abdallah R. Somatic symptom disorders and utilization of health services among Palestinian primary health care attendees: a cross-sectional study. BMC Health Serv Res. (2021) 21:615. doi: 10.1186/s12913-021-06671-2
35. Bener A, Al-Kazaz M, Ftouni D, Al-Harthy M, and Dafeeah EE. Diagnostic overlap of depressive, anxiety, stress and somatoform disorders in primary care. Asia-Pacific Psychiatry: Off J Pacific Rim Coll Psychiatrists. (2013) 5:E29–38. doi: 10.1111/j.1758-5872.2012.00215.x
36. Bener A, Dafeeah EE, Chaturvedi SK, and Bhugra D. Somatic symptoms in primary care and psychological comorbidities in Qatar: Neglected burden of disease. Int Rev Psychiatry. (2013) 25:100–6. doi: 10.3109/09540261.2012.730993
37. Bener A, Ghuloum S, Al-Mulla AAK, Al-Marri S, Hashim MS, and Elbagi I-EA. Prevalence of somatisation and psychologisation among patients visiting primary health care centres in the State of Qatar. Libyan J Med. (2010) 5:5266–73. doi: 10.3402/ljm.v3405i3400.5266
38. Bener A, Ghuloum S, and Burgut FT. Gender differences in prevalence of somatoform disorders in patients visiting primary care centers. J Primary Care Community Health. (2010) 1:37–42. doi: 10.1177/2150131909353333
39. Aleyeidi N, Fayed A, Alnowaiser G, Aldubayyan R, Alfahhad L, Alhosaini J, et al. Cyberchondria, somatic symptoms, and internet-based self-diagnosis among the Saudi population. Sci Rep. (2025) 15:18208. doi: 10.1038/s41598-025-02612-9
40. Alqahtani MM and Salmon P. Prevalence of somatization and minor psychiatric morbidity in primary healthcare in Saudi Arabia: a prelimininary study in Asir region. J Family Community Med. (2008) 15:27–33. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377053/.
41. Hiar S, Thomas CL, Hinton DE, Salles J, Goutaudier N, Olliac B, et al. Somatic symptoms mediate the relationship between trauma during the arab spring and quality of life among Tunisians. J Nervous Ment Dis. (2016) 204:153–5. doi: 10.1097/NMD.0000000000000446
42. El-Rufaie OEF, Al-Sabosy MMA, Bener A, and Abuzeid MSO. Somatized mental disorder among primary care arab patients: I. prevalence and clinical and sociodemographic characteristics. J Psychosomatic Res. (1999) 46:549–55. doi: 10.1016/S0022-3999(98)00101-9
43. Mahmoud I and Saravanan C. Prevalence of mental disorders and the use of mental health services among the adult population in United Arab Emirates. Asian J Epidemiol. (2020) 13:12–9. doi: 10.3923/aje.2020.12.19
44. Borho A, Morawa E, Schmitt GM, and Erim Y. Somatic distress among Syrian refugees with residence permission in Germany: analysis of a cross-sectional register-based study. BMC Public Health. (2021) 21:896. doi: 10.1186/s12889-021-10731-x
45. McGrath M, Acarturk C, Roberts B, Ilkkursun Z, Sondorp E, Sijbrandij M, et al. Somatic distress among Syrian refugees in Istanbul, Turkey: A cross-sectional study. J Psychosomatic Res. (2020) 132:109993. doi: 10.1016/j.jpsychores.2020.109993
46. El-Gabry DA, Aziz KA, Al-Hosani MH, Aljneibi MK, Shouma A, Zeid DA, et al. Frequency of illness anxiety (hypochondriasis) by proxy encountered by doctors in parents towards their children. Ann Clin Psychiatry: Off J Am Acad Clin Psychiatrists. (2022) 34:254–62. doi: 10.12788/acp.0083
47. Terra M, Baklola M, Mansour LS, Darwish NE, Badr ME, Alghazali AA, et al. The association of health anxiety with quality of life among medical students in Egypt: Myth or Menace? BMC Psychiatry. (2024) 24:895. doi: 10.1186/s12888-024-06313-x
48. Alsamhori JF, Rihani J, Shaban L, Omeish R, Alsamhori ARF, Alsamhori AF, et al. Illness anxiety symptoms among medical students in Jordan: a cross-sectional study. Middle East Curr Psychiatry. (2025) 32:58. doi: 10.1186/s43045-025-00551-9
49. Bilani N, Jamali S, Chahine A, Zorkot M, Homsi M, Saab M, et al. Illness cognition and health anxiety in parents of children with cancer. J Psychosocial Oncol. (2019) 37:713–28. doi: 10.1080/07347332.2019.1600629
50. Ezmeirlly HA and Farahat FM. Illness anxiety disorder and perception of disease and distress among medical students in western Saudi Arabia. Saudi Med J. (2019) 40:1144–9. doi: 10.15537/smj.2019.11.24654
51. Hawamdeh S, Moussa FL, Al-Rawashdeh S, Hawamdih SA, and Moussa ML. Illness anxiety disorder and distress among female medical and nursing students. Clin Pract Epidemiol Ment Health. (2023) 19:e17450179277976. doi: 10.2174/0117450179277976231115070100
52. Abdel Aziz K, Stip E, Al-Sanadi A, Al-Shamsi A, Al-Sharqi H, Eisa Al-Zaabi M, et al. Prevalence and correlates of health anxiety among medical students: a cross-sectional study from the United Arab Emirates. Middle East Curr Psychiatry. (2023) 30:3. doi: 10.1186/s43045-022-00273-2
53. Chand SP, Koul R, and Al Hussaini AA. Conversion and dissociative disorders in the Sultanate of Oman. J Am Acad Child Adolesc Psychiatry. (2001) 40:869–70. doi: 10.1097/00004583-200108000-00005
54. Wilkins SS, Mesraoua B, Palomo GA, Al Hail H, Salam A, Melikyan G, et al. Characteristics of patients with confirmed epilepsy and psychogenic nonepileptic seizures in Qatar. Epilepsy Behav. (2018) 85:218–21. doi: 10.1016/j.yebeh.2018.06.014
55. Hamdy NA, Alamgir MJ, Mohammad EGE, Khedr MH, and Fazili S. Profile of epilepsy in a regional hospital in al qassim, Saudi Arabia. Int J Health Sci. (2014) 8:247–55. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257360/.
56. Tayeb HO. Functional neurological disorder in Saudi Arabia: A retrospective study. Int J Psychiatry Med. (2023) 59:569–82. doi: 10.1177/00912174231215908
57. Bhargava D, Al-Abri R, Rizvi SGA, Al Okbi MH, Bhargava K, and Al-Adawi S. Phenomenology and outcome of factitious disorders in otolaryngology clinic in Oman. Int J Psychiatry Med. (2007) 37:229–40. doi: 10.2190/3175-282H-11U4-1U07
58. Karadsheh MF. Bloody tears: A rare presentation of munchausen syndrome case report and review. J Family Med Primary Care. (2015) 4:132–4. doi: 10.4103/2249-4863.152271
59. Bappal B, George M, Nair R, Khusaiby SA, and De Silva V. Factitious hypoglycemia: a tale from the Arab world. Pediatrics. (2001) 107:180–1. doi: 10.1542/peds.107.1.180
60. Al-Habeeb TA. Factitious disorder in Saudi Arabia: A report of two cases. J Family Community Med. (1999) 6:49–52. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437074/.
61. Arabi H, Babiker A, Awadalla AM, Ababneh F, and AlMuneef MA. Factitious hypoglycemia in an infant with undetectable exogenous insulin by a commercial insulin immunoassay: A diagnostic pitfall. Cureus. (2023) 15:e33224. doi: 10.7759/cureus.33224
62. MacFarland AS, Al-Maashani M, Al Busaidi Q, Al-Naamani A, El-Bouri M, and Al-Adawi S. Culture-specific pathogenicity of dhat (Semen loss) syndrome in an arab/islamic society, Oman. Oman Med J. (2017) 32:251–5. doi: 10.5001/omj.2017.47
63. Rometsch C, Mansueto G, Maas Genannt Bermpohl F, Martin A, and Cosci F. Prevalence of functional disorders across Europe: a systematic review and meta-analysis. Eur J Epidemiol. (2024) 39:571–86. doi: 10.1007/s10654-024-01109-5
64. Creed F and Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosomatic Res. (2004) 56:391–408. Available online at: https://research.manchester.ac.uk/en/publications/a-systematic-review-of-the-epidemiology-of-somatisation-disorder-files/719/a-systematic-review-of-the-epidemiology-of-somatisation-disorder-.html (Accessed July 7, 2025).
65. Ferrari S, Galeazzi GM, Mackinnon A, and Rigatelli M. Frequent attenders in primary care: impact of medical, psychiatric and psychosomatic diagnoses. Psychother Psychosom. (2008) 77:306–14. doi: 10.1159/000142523
66. Hoedeman R, Blankenstein AH, Krol B, Koopmans PC, and Groothoff JW. The contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge. J Occup Rehabil. (2010) 20:264–73. doi: 10.1007/s10926-010-9239-3
67. Ballering AV, Bonvanie IJ, Olde Hartman TC, Monden R, and Rosmalen JGM. Gender and sex independently associate with common somatic symptoms and lifetime prevalence of chronic disease. Soc Sci Med. (2020) 53:112968. doi: 10.1016/j.socscimed.2020.112968
68. Kirmayer LJ and Sartorius N. Cultural models and somatic syndromes. Psychosomatic Med. (2007) 69:832–40. doi: 10.1097/PSY.0b013e31815b002c
69. Afari N, Ahumada SM, Wright LJ, Mostoufi S, Golnari G, Reis V, et al. Psychological trauma and functional somatic syndromes: A systematic review and meta-analysis. Psychosomatic Med. (2014) 76:2–11. doi: 10.1097/PSY.0000000000000010
70. Gillespie NA, Zhu G, Heath AC, Hickie IB, and Martin NG. The genetic aetiology of somatic distress. psychol Med. (2000) 30:1051–61. doi: 10.1017/s0033291799002640
71. Claassen-van Dessel N, van der Wouden JC, Hoekstra T, Dekker J, and van der Horst HE. The 2-year course of Medically Unexplained Physical Symptoms (MUPS) in terms of symptom severity and functional status: results of the PROSPECTS cohort study. J Psychosomatic Res. (2018) 104:76–87. doi: 10.1016/j.jpsychores.2017.11.012
72. Lien L, Claussen B, Hauff E, Thoresen M, and Bjertness E. Bodily pain and associated mental distress among immigrant adolescents. Eur Child Adolesc Psychiatry. (2005) 14:371–5. doi: 10.1007/s00787-005-0484-5
73. Rometsch C, Denkinger JK, Engelhardt M, Windthorst P, Graf J, Gibbons N, et al. Pain, somatic complaints, and subjective concepts of illness in traumatized female refugees who experienced extreme violence by the “Islamic State” (IS). J Psychosomatic Res. (2020) 130:109931. doi: 10.1016/j.jpsychores.2020.109931
74. Rohlof HG, Knipscheer JW, and Kleber RJ. Somatization in refugees: a review. Soc Psychiatry Psychiatr Epidemiol. (2014) 49:1793–804. doi: 10.1007/s00127-014-0877-1
75. Shidhaye R, Mendenhall E, Sumathipala K, Sumathipala A, and Patel V. Association of somatoform disorders with anxiety and depression in women in low- and middle-income countries: A systematic review. Int Rev Psychiatry (Abingdon England). (2013) 25:65–76. doi: 10.3109/09540261.2012.748651
76. Cooper A, Abbass A, Zed J, Bedford L, Sampalli T, and Town J. Implementing a psychotherapy service for medically unexplained symptoms in a primary care setting. J Clin Med. (2017) 6:109. Available online at: https://www.mdpi.com/2077-0383/6/12/109 (Accessed July 7, 2025).
77. Henningsen P. Management of somatic symptom disorder. Dialogues Clin Neurosci. (2018) 20:23–31. doi: 10.31887/DCNS.2018.20.1/phenningsen
78. Hartman T, Borghuis M, Lucassen P, Van de Laar F, Speckens A, and Van Weel C. Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosomatic Res. (2009) 66:363–77. doi: 10.1016/j.jpsychores.2008.09.018
79. Robert MM. Somatization in the primary care setting. Psychiatr Times. (2006) 23. Available online at: https://www.psychiatrictimes.com/view/somatization-primary-care-setting (Accessed June 6, 2025).
80. Henningsen P, Zipfel S, Sattel H, and Creed F. Management of functional somatic syndromes and bodily distress. Psychother Psychosom. (2018) 87:12–31. doi: 10.1159/000484413
81. Nair SS, Kwan SC, Ng CWM, and Teo DCL. Approach to the patient with multiple somatic symptoms. Singapore Med J. (2021) 62:252–8. doi: 10.11622/smedj.2021059
82. Röhricht F, Green C, Filippidou M, Lowe S, Power N, Rassool S, et al. Integrated care model for patients with functional somatic symptom disorder – a co-produced stakeholder exploration with recommendations for best practice. BMC Health Serv Res. (2024) 24:698. doi: 10.1186/s12913-024-11130-9
83. Alqasir A and Ohtsuka K. The impact of religio-cultural beliefs and superstitions in shaping the understanding of mental disorders and mental health treatment among arab muslims. J Spirituality Ment Health. (2024) 26:279–302. doi: 10.1080/19349637.2023.2224778
84. Khoury B, Rafeh M, and Bou Dargham Z. Traditional healing for physical and mental problems in the Arab region: past and current practices. BJPsych Int. (2024) 21:44–6. doi: 10.1192/bji.2024.3
85. Azuri J, Ackshota N, and Vinker S. Reassuring the medical students’ disease – Health related anxiety among medical students. Med Teacher. (2010) 32:e270–5. doi: 10.3109/0142159X.2010.490282
86. Eley DS and Slavin SJ. Medical student mental health – the intransigent global dilemma: Contributors and potential solutions. Med Teacher. (2024) 46:156–61. doi: 10.1080/0142159X.2023.2279909
87. Panepinto JA, Hoffmann RG, and Pajewski NM. The effect of parental mental health on proxy reports of health-related quality of life in children with sickle cell disease. Pediatr Blood Cancer. (2010) 55:714–21. doi: 10.1002/pbc.22651
88. Pinquart M. Meta-analysis of anxiety in parents of young people with chronic health conditions. J Pediatr Psychol. (2019) 44:959–69. doi: 10.1093/jpepsy/jsz024
89. Jungilligens J, Michaelis R, and Popkirov S. Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks. J Neurology Neurosurg & Psychiatry. (2021) 92:1341. doi: 10.1136/jnnp-2021-326443
90. Kanemoto K, LaFrance WC Jr., Duncan R, Gigineishvili D, Park S-P, Tadokoro Y, et al. PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps—an ILAE PNES Task Force report. Epilepsia Open. (2017) 2:307–16. doi: 10.1002/epi4.12060
91. Liampas A, Markoula S, Zis P, and Reuber M. Psychogenic non-epileptic seizures (PNES) in the context of concurrent epilepsy – making the right diagnosis. Acta Epileptologica. (2021) 3:23. doi: 10.1186/s42494-021-00057-x
92. Pretorius C. Barriers and facilitators to reaching a diagnosis of PNES from the patients’ perspective: Preliminary findings. Seizure. (2016) 38:1–6. doi: 10.1016/j.seizure.2016.03.007
93. Mianji F and Semnani Y. Zār spirit possession in Iran and african countries: group distress, culture-bound syndrome or cultural concept of distress? Iran J Psychiatry. (2015) 10:225–32.
94. Barsky AJ, Peekna HM, and Borus JF. Somatic symptom reporting in women and men. J Gen Internal Med. (2001) 16:266–75. doi: 10.1046/j.1525-1497.2001.00229.x
95. Faravelli C, Salvatori S, Galassi F, Aiazzi L, Drei C, and Cabras P. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol. (1997) 32:24–9. doi: 10.1007/BF00800664
96. Rief W, Mewes R, Martin A, Glaesmer H, and Brähler E. Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms. Psychosomatic Med. (2011) 73:760–8. doi: 10.1097/PSY.0b013e318234eff6
97. van Wijk CM and Kolk AM. Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med. (1997) 45:231–46. doi: 10.1016/s0277-9536(96)00340-1
98. Yu S. Uncovering the hidden impacts of inequality on mental health: a global study. Trans Psychiatry. (2018) 8:98. doi: 10.1038/s41398-018-0148-0
99. Al-Krenawi A and Graham JR. Culturally sensitive social work practice with Arab clients in mental health settings. Health Soc Work. (2000) 25:9–22. doi: 10.1093/hsw/25.1.9
100. Sabry WM and Vohra A. Role of Islam in the management of Psychiatric disorders. Indian J Psychiatry. (2013) 55:S205–14. doi: 10.4103/0019-5545.105534
101. Kleinman A. Patients and healers in the context of culture: An exploration of the borderland between anthropology, medicine, and psychiatry (Vol. 3). Berkeley & Los Angeles, CA: Univ of California Press (1980).
102. Rassool GH. Evil eye, jinn possession, and mental health issues: An Islamic perspective. London & New York: Routledge (2018).
103. Alhorany A. Attitudes toward Help-seeking Counseling, Stigma in Arab context: A Systematic Literature Review. Malays J Med Health Sci. (2019) 15:160–7.
104. Fekih-Romdhane F, Daher-Nashif S, Stambouli M, Alhuwailah A, Helmy M, Shuwiekh HAM, et al. Mental illness stigma as a moderator in the relationship between religiosity and help-seeking attitudes among Muslims from 16 Arab countries. BMC Public Health. (2023) 23:1671. doi: 10.1186/s12889-023-16622-7
105. Lim A, Hoek HW, Ghane S, Deen M, and Blom JD. The attribution of mental health problems to jinn: an explorative study in a transcultural psychiatric outpatient clinic. Front Psychiatry. (2018) 9:3389/fpsyt.2018.00089. doi: 10.3389/fpsyt.2018.00089
106. Gelauff J and Stone J. Prognosis of functional neurologic disorders. In: Handbook of clinical neurology, vol. 139. Amsterdam, Netherlands: Elsevier (2016). p. 523–41. doi: 10.1016/B978-0-12-801772-2.00043-6
107. Hall-Patch L, Brown R, House A, Howlett S, Kemp S, Lawton G, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia. (2010) 51:70–8. doi: 10.1111/j.1528-1167.2009.02099.x
108. Perjoc R-S, Roza E, Vladacenco OA, Teleanu DM, Neacsu R, and Teleanu RI. Functional neurological disorder–old problem new perspective. Int J Environ Res Public Health. (2023) 20:1099. doi: 10.3390/ijerph20021099
109. Raghuram H, Rajguru AJ, Pathiyil MM, Brahmbhatt A, Bhan A, Spagnolo J, et al. Characterizing modifications to the mental health gap action programme (mhGAP) intervention guide during implementation in low- and middle-income countries using the framework for reporting adaptations and modifications to evidence-based interventions: a systematic review of reviews. Int J Ment Health Syst. (2025) 19:20. doi: 10.1186/s13033-025-00671-z
Keywords: somatic symptom disorder, illness anxiety, functional neurological symptom disorder, factitious disorder, Arab countries
Citation: Eid M, Abi Kheir V, Bizri M, Larnaout A and El Hayek S (2025) Somatic symptom and related disorders in the Arab world: a narrative review of clinical features and care implications. Front. Psychiatry 16:1692267. doi: 10.3389/fpsyt.2025.1692267
Received: 25 August 2025; Accepted: 14 November 2025; Revised: 09 November 2025;
Published: 12 December 2025.
Edited by:
Hong Wang Fung, The Hong Kong Polytechnic University, Hong Kong SAR, ChinaReviewed by:
Paul Hüsing, University Medical Center Hamburg-Eppendorf, GermanyAnson Kai Chun Chau, The University of Hong Kong, Hong Kong SAR, China
Copyright © 2025 Eid, Abi Kheir, Bizri, Larnaout and El Hayek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Samer El Hayek, c2FtZXIuZWxoYXlla0BnbWFpbC5jb20=